Litcius/Paper detail

Combination therapy of acute myeloid leukemia by dual PI3K/mTOR inhibitor BEZ235 and TLR-7/8 agonist R848 in murine model

Saeid Taghiloo, Abolghasem Ajami, Reza Alizadeh‐Navaei, Hossein Asgarian‐Omran

2023International Immunopharmacology11 citationsDOI

Topics & Concepts

MedicineCD8Immune systemMyeloid leukemiaImmunologyCancer researchImmune cells in cancerAcute Myeloid Leukemia ResearchPI3K/AKT/mTOR signaling in cancer
Combination therapy of acute myeloid leukemia by dual PI3K/mTOR inhibitor BEZ235 and TLR-7/8 agonist R848 in murine model | Litcius